- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/14 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
Patent holdings for IPC class C07D 317/14
Total number of patents in this class: 25
10-year publication summary
|
3
|
3
|
1
|
1
|
1
|
0
|
2
|
0
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Johns Hopkins University | 5898 |
6 |
| Bayer Cropscience AG | 1838 |
2 |
| Gfbiochemicals Limited | 50 |
2 |
| Segetis, Inc. | 38 |
2 |
| LG Chem, Ltd. | 17937 |
1 |
| Ambrx, Inc. | 169 |
1 |
| Firmenich SA | 1763 |
1 |
| Gelion Technologies Pty Ltd | 66 |
1 |
| The Hong Kong University of Science and Technology | 156 |
1 |
| Kyzen Corporation | 32 |
1 |
| Rowan University | 196 |
1 |
| Siteone Therapeutics, Inc. | 22 |
1 |
| Solvay Specialty Polymers Italy S.p.A. | 655 |
1 |
| The University of York | 173 |
1 |
| Prelude Therapeutics, Incorporated | 147 |
1 |
| Metrochem API Pvt Ltd. | 12 |
1 |
| LG Energy Solution, Ltd. | 19136 |
1 |
| Other owners | 0 |